Volume | 1,640,232 |
|
|||||
News | - | ||||||
Day High | 147.175 | Low High |
|||||
Day Low | 145.95 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | JNJ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
146.70 | 145.95 | 147.175 | 146.82 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
46,583 | 1,640,232 | $ 146.65 | $ 240,533,806 | - | 143.13 - 175.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:52:32 | 1 | $ 146.6398 | USD |
Johnson and Johnson (JNJ) Options Flow Summary
Johnson and Johnson Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
353.05B | 2.41B | - | 85.16B | 35.15B | 14.59 | 10.04 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Johnson and Johnson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 146.01 | 150.49 | 144.54 | 148.47 | 9,473,212 | 0.62 | 0.42% |
1 Month | 157.87 | 158.15 | 143.13 | 149.30 | 8,132,609 | -11.24 | -7.12% |
3 Months | 157.97 | 163.11 | 143.13 | 155.17 | 7,714,043 | -11.34 | -7.18% |
6 Months | 151.63 | 163.58 | 143.13 | 155.16 | 7,251,944 | -5.00 | -3.30% |
1 Year | 164.09 | 175.97 | 143.13 | 162.61 | 10,983,219 | -17.46 | -10.64% |
3 Years | 165.21 | 186.69 | 143.13 | 165.95 | 8,457,481 | -18.58 | -11.25% |
5 Years | 139.88 | 186.69 | 109.16 | 157.54 | 8,165,001 | 6.75 | 4.83% |
Johnson and Johnson Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |